甲状腺结节
医学
甲状腺机能正常
结核(地质)
甲状腺
内分泌系统
协商一致会议
普通外科
内科学
激素
生物
古生物学
作者
Fabrice Ménégaux,Grégory Baud,Nathalie Chéreau,Niki Christou,Sophie Deguelte,Scott H. Frey,Carole Guérin,Camille Marciniak,Nunzia Cinzia Paladino,Laurent Brunaud,Robert Caïazzo,Gianluca Donatini,Sébastien Gaujoux,P. Goudet,Dana M. Hartl,Jean-Christophe Lifante,Muriel Mathonnet,Éric Mirallié,H. Najah,F. Sébag,Christophe Trésallet,François Pattou
标识
DOI:10.1016/j.ando.2022.10.012
摘要
The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French-speaking Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). This section deals with the surgical management of thyroid nodules.
科研通智能强力驱动
Strongly Powered by AbleSci AI